Benzbromarone Tablets
Function and Efficacy
This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood.
Ingredients
The main ingredient of this product is benzbromarone. Chemical name: (3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-3-benzofuranyl) ketone
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| BenzbromaroneIngredients |
This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood. More |
3562-84-3 | 8 |
Appearance
This product is a white tablet.
Indication
Primary hyperuricemia, intermittent period of gouty arthritis and gouty nodules, etc.
Usage and Dosage
Adults take 50 mg orally once a day after breakfast. Check the patient's serum uric acid concentration after 1-3 weeks of medication. When it drops to the normal range, change to 50-100 mg per day, or follow the doctor's advice.
Adverse Reactions
Generally, patients have good tolerance to this product, but sometimes they may experience: 1. Digestive system symptoms such as diarrhea, stomach discomfort, nausea, etc. 2. Skin allergies such as wheals, rashes, flushing, itching, etc. 3. Increased GOT, GPT and alkaline phosphatase.
Precautions
1. Patients with moderate to severe renal impairment (glomerular filtration rate less than 20ml/min and those with nephritis) are prohibited from using this product. 2. Pregnant women or women who may become pregnant and breastfeeding women are prohibited from using this product.
Special Population Medication
Precautions for children: The safety and effectiveness of this product for children have not been studied, so it is not recommended for children. Precautions for pregnancy and lactation: 1. Since there is no clinical experience in humans and there are deviations in animal experimental results, it is contraindicated for pregnant patients. 2. It is not clear whether benzbromarone enters breast milk, so it is contraindicated for lactating patients. Precautions for the elderly: The physiological functions of the elderly generally decline, so the dosage should be reduced or follow the doctor's advice.
Drug Interactions
The uricosuric effect of benzbromarone may be attenuated by salicylates and sulfinpyrazone.
Storage
Keep sealed.
Packaging Specification
50 mg
Validity Period
60 months
Manufacturer
Changzhou Kangpu Pharmaceutical Co., Ltd.
-
Founded in:
1979-12-01 -
Address:
No. 6, Jingde East Road, Qianhuang Town, Wujin District -
Tax NO.:
91320412250816627K -
Registered Funds:
20 million yuan -
Website:
-
Email: